B. Metzler seel. Sohn & Co’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Hold
81,098
0.03% 291
2026
Q1
$2.69M Buy
81,098
+21,633
+36% +$703K 0.02% 320
2025
Q4
$1.95M Buy
+59,465
New +$1.46M 0.02% 414

Other funds holding AXGN

B. Metzler seel. Sohn & Co's AXGN Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co held its Axogen (AXGN) position steady in Q2 2026 at 81,098 shares worth $3.75M. The position accounts for 0.03% of the portfolio, ranked #291.

B. Metzler seel. Sohn & Co first reported a position in AXGN in Q4 2025 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 81,098 shares of Axogen worth $3.75M as of Q2 2026.
  • B. Metzler seel. Sohn & Co left its Axogen share count unchanged in Q2 2026.
  • Axogen made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #291 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Axogen in Q4 2025 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.